Statement of Practice Summary:
Antitrust, Appellate, Asia, Bankruptcy, Biotech, Pharma & Life Science, Chemicals, Collateralized Debt Obligation, Company Secretarial, Construction & Engineering, Corporate & Securities, Corporate Governance, Derivatives, E-commerce, Emerging Companies, Employee Benefits & Executive Compensation, Employee Share Incentives, Employment & Labour, Energy, Environment, Finance, Financial Services, Global Trade, Government, Government Contracts, Health Care, Information Technology, Insurance & Reinsurance, Intellectual Property, International Arbitration, Investment Management, Latin America, Legislative, Litigation & Dispute Resolution, Natural Resources, Outsourcing, Pensions, PPP/PFI & Infrastructure, Private Equity, Private Investment Fund, Pro Bono, Professional Practices, Project Finance, Property Rights, Public Law, Rail, Real Estate, Regulated Industries, Restructuring & Insolvency, Securitisation, Tax Controversy & Transfer Pricing, Tax Transactions & Consulting, Telecommunications & Media, Venture & Technology, Wealth Management.
UK, US and Hong Kong Listings - Eligibility and Continuing Obligations
Kate Ball-Dodd,Robert Hamill, September 12, 2014
In our Equity Capital Markets Spotlight, we compare the eligibility requirements for companies seeking to list their equity securities on the UK, US and Hong Kong markets, together with the continuing obligations which apply once listed.